Drug Shortage Report for DILANTIN
| Report ID | 176202 |
| Drug Identification Number | 00022772 |
| Brand name | DILANTIN |
| Common or Proper name | DILANTIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYTOIN SODIUM |
| Strength(s) | 30MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-01-16 |
| Actual start date | |
| Estimated end date | 2023-03-14 |
| Actual end date | 2023-03-07 |
| Shortage status | Resolved |
| Updated date | 2023-03-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-03-20 | French | Compare |
| v7 | 2023-03-20 | English | Compare |
| v6 | 2023-02-14 | French | Compare |
| v5 | 2023-02-14 | English | Compare |
| v4 | 2023-01-17 | French | Compare |
| v3 | 2023-01-17 | English | Compare |
| v2 | 2022-11-29 | French | Compare |
| v1 | 2022-11-29 | English | Compare |
Showing 1 to 8 of 8